Will Stoddart

Will Stoddart is a seasoned medical and tech executive known for his experience in founding, growing, and scaling healthcare internet businesses.

He has a strong background in CEO roles, fundraising, customer acquisition, business development, product development, business operations, and strategy, with a primary interest in the field of ageing.

Currently, Will is the founder at Melio, a venture focused on keeping individuals 'Younger for Longer'.

Before Melio, he served as the CEO of Werlabs, where he successfully transformed the company into Scandinavia's largest consumer blood-testing provider serving a population of over 4 million people.

Prior to Werlabs, Will was a founder at Haploflow, a venture concentrating on leveraging wearable data to assist individuals in making informed decisions.

Will Stoddart pursued his education at William Hulme's Grammar School and graduated with a BA (Hons) in Finance with a 2:1 from Durham University.

Throughout his career, he has held key positions such as Founder at Melio, former CEO at Werlabs, Operations Manager at Werlabs, CEO at Haploflow, Functional Services Specialist at SunGard, Diplomatic Services at the U.S. Department of State, and Senior Advisor at Tilney Bestinvest.